Serologic Testing for Rubella
July 2008
Dr. Binnicker reviews the epidemiology of rubella and a patient case. Dr. Binnicker discusses how the conclusion that rubella is no longer endemic in the United States has changed the laboratory approach to diagnosis. As a result of these changes, Mayo Medical Laboratories has discontinued IgM-class antibody testing for rubella.
Presenter:
- Matt Binnicker, PhD, D(ABMM)) from the Division of Clinical Microbiology at Mayo Clinic
Print Options
- Before viewing, print the Notes Pages.
- After viewing, obtain a Record of Viewing.
Forward to a Colleague
If you have questions, e-mail
External
link
PDF
document
Excel
document
Word
document